IHE:NYE-iShares U.S. Pharmaceuticals ETF (USD)

ETF | Health |

Last Closing

USD 67.5

Change

0.00 (0.00)%

Market Cap

N/A

Volume

0.02M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-06-15 )

ETFs Containing IHE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.71% 90% A- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.71% 90% A- 63% D
Trailing 12 Months  
Capital Gain 1.95% 76% C+ 50% F
Dividend Return 0.54% 60% D- 8% B-
Total Return 2.49% 76% C+ 40% F
Trailing 5 Years  
Capital Gain 32.72% 86% B+ 54% F
Dividend Return 8.72% 95% A 21% F
Total Return 41.43% 90% A- 47% F
Average Annual (5 Year Horizon)  
Capital Gain 2.30% 67% D+ 48% F
Dividend Return 3.67% 67% D+ 44% F
Total Return 1.37% 100% F 32% F
Risk Return Profile  
Volatility (Standard Deviation) 14.03% 62% D 66% D+
Risk Adjusted Return 26.15% 71% C- 46% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike